ESC Premium Access

Adherence to international guidelines on diuretic treatment in heart failure based on congestive signs in 43,744 patients from SwedeHF

Congress Presentation

About the speaker

Doctor Par Paren

Sahlgrenska University Hospital, Gothenburg (Sweden)
0 follower

9 more presentations in this session

The risk of atrial fibrillation with ivabradine treatment: A meta-analysis with trial sequential analysis of over 40000 patients

Speaker: Associate Professor I. Tanboga (Istanbul, TR)


Differential impacts of digoxin modulated by volume status on one-year mortality in patients with acute heart failure

Speaker: Doctor W. Wang (Taipei, TW)


Dosage-dependent association between betablocker therapy with Carvedilol or Metoprolol and the risk of appropriate ICD therapy in primary prevention ICD patients.

Speaker: Doctor A. Huth Ruwald (Copenhagen, DK)


The cost-effectiveness of sacubitril/valsartan (LCZ696) in the treatment of patients with heart failure with reduced ejection fraction in Norway


Effect of in-hospital treatment on short-term mortality of elderly versus non-elderly patients hospitalized for acute heart failure

Speaker: Doctor S. Katsanos (Athens, GR)


Access the full session

Pharmacologic approaches in HF: could we do better?

Speakers: Doctor P. Paren, Associate Professor I. Tanboga, Doctor W. Wang, Doctor A. Huth Ruwald, Doctor S. Katsanos

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb